|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Optimal chemotherapy for advanced gastric cancer: is there a global consensus?显示文摘 | Florian Lordick Sylvie Lorenzen Yasuhide Yamada David Ilson | 2014 | Gastric Cancer2014，，2： | 3 |
| 2 | Diagnosis and management of pituitary abscess: review of twenty-four cases 显示文摘 | Vates GE erger MS ilson CB t al | 2001 | J Neurosurg2001，5，2： | 2 |
| 3 | New developments in the treatment of esophageal cancer 显示文摘 | Ilson DH | 2002 | Curt Oncol Rep2002，4，3： | 1 |
| 4 | Multicenter phase Ⅱ study of irinotecan,cisplatin,and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma显示文摘 | Shah MA Ramanathan RK Ilson DH | 2006 | J Clio Oncol2006，24，33： | 1 |
| 5 | Phase Ⅱ trial of weekly irintecan plus cisplatin in advanced esophageal cancer 显示文摘 | Ilson DH Saltz I Enzinger P | 1999 | J Clin Oncol1999，17，10： | 1 |
| 6 | Oesophageal cancer:new developments in systemic therapy显示文摘 | Ilson DH | 2003 | Cancer Treat Rev2003，29，6： | 1 |
| 7 | Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face 显示文摘 | Fata F O'Reilly E Ilson D | 1999 | Cancer1999，86，10： | 1 |
| 8 | Analysis of survival with modified docetaxel,cisplatin,fluorouracil(mDCF),and bevacizumab(BEV)in patients with metastatic gastroesophageal(GE)adenocarcinoma:results of a phase II clinical trial显示文摘 | Kelsen D Jhawer M Ilson D | 2009 | J Clin Oncol2009，，： | 1 |
| 9 | Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face 显示文摘 | Fata F O' Reilly E Ilson D | 1999 | Cancer1999，86，10： | 1 |
| 10 | Chemotherapy in esophagealcancer显示文摘 | Enzinger PC Ilson DH Kelsen DP | 1999 | Semin Oncol1999，26，： | 1 |
| 11 | Analysis of survival with modified docetaxel,cisplatin,fluorouracil(mDCF),and bevacizumab(BEV) in patients with metastatic gastroesophageal(GE)adenocarcinoma:Results of a phase Ⅱ clinical trial显示文摘 | Kelsen D Jhawer M Ilson D | 2009 | ASCO Meeting2009，27，： | 1 |
| 12 | Treatment of localized esophageal cancer显示文摘 | Brenner B Ilson DH Minsky BD | 2004 | Semin Oncol2004，，： | 1 |
| 13 | Targeted therapies for esophagealcancer显示文摘 | Tew WP Kelsen DP Ilson DH | 2005 | Oncologist2005，10，8： | 1 |
| 14 | Pacli*axel given by a weekly 1-h infusion in advanced esophageal cancer显示文摘 | Ilson D H Wadleigh R G Leichman L P | 2007 | AnnOncol2007，18，7： | 1 |
| 15 | Black, Venture Capital andStructure Capital M arkets: Banks Versus Stock Markets 显示文摘 | Ronald J G ilson Benard S | 1998 | Journal o f Financial Econom ic1998，47，3： | 1 |
| 16 | A dose-response study to assess the renal hemodynamic,vascular and hormonal effects of eprosartan:an angiotensin Ⅱ AT1 receptor antagonist insodium-replete healthy men显示文摘 | Boike S C Martin D E | 1998 | Clin Pharmacol Ther1998，63，4： | 1 |
| 17 | A phase Ⅱ trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus显示文摘 | Ilson DH Forastiere A ArquetteM | 2000 | Cancer J2000，6，5： | 1 |
| 18 | A Multi - centerPhase Ⅱ study of Irinotecan ( CPT), Cisplatin ( CIS ), and Bevacizumab(BEV) in patients with unresectable ormeta- static gastric or gas troesophageal junction (GEJ) adenocarcinoma 显示文摘 | Shah M A Ilson D Ramanathan R K | 2005 | Proc Am Soc ClinOncol2005，24，： | 1 |
| 19 | Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer显示文摘 | ILSON D H BAINS M KELSEN D P | 2003 | J Clin Oncol2003，21，15： | 1 |
| 20 | Treatment of localized esophageal cancer 显示文摘 | Brenner B Ilson DH Minsky BD | 2004 | Semin Oncol2004，31，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员